Executive Director, Patient Support Services

Waltham, MA

The Executive Director, Patient Support Services is responsible for developing patient service strategies that maximize patient access to therapies; design and build patient support programs with outside hub vendors and other providers. The ED will have direct oversight of the Case Management Team and Field Reimbursement Team.

• Develop patient service strategies that maximize patient access to therapies; design and build patient support programs with outside hub vendors and other providers.
• Set strategy, identify and select hub partner, and construct a best-in-class patient support program.
• Provide leadership oversight and management for the effective functioning of the hub by establishing and monitoring program goals and key performance indicators.
• Communicate hub performance to stakeholders through dashboards and implement improvement plans as needed.
• Build and lead strategies addressing patient-level barriers to product access.
• Drive innovation and program enhancements to optimize customer service and patient access to therapies by identifying emerging opportunities.
• Establish analytic rigor within patient services and support data‑driven decision‑making for the commercial business.
• Build and develop productive working relationships with external service providers and internal cross‑functional stakeholders, such as data aggregators, specialty pharmacies and internal commercial operations and legal teams.
• Ensure effective and compliant implementation of Patient Financial Assistance programs.
• Lead and manage the Field Reimbursement Team providing clear direction, coaching, performance management and annual goal setting.

• Bachelors Degree Required / Masters Degree Preferred
• 15 or more years working in the pharma/biotech space, with at least 10+ years working in patient support services.
• Strong track record of leading teams, both internal and/or field based.
• Proactive, results‑oriented, self‑starter with expertise in reimbursement environments.
• Understanding of the orphan neurodegenerative disease marketplace and the specific access support needs for patients with Huntington’s Disease.
• Demonstrated ability to build organizational capability and deep experience developing and managing manufacturer hub operations or specialty drug patient services/call center inclusive of FRM field function.
• In‑depth knowledge of pharmaceutical manufacturer compliance, patient confidentiality, product reimbursement and product access requirements.
• Knowledge of regulations and laws governing the protection of PHI (patient health information), and CMS policies pertaining to access services.
• Strategic planning and execution skills including operations management, project/budget management, and working effectively with external service partners.
• Proven track record developing and delivering patient access and reimbursement solutions in a high impact and cost‑effective way.
• Strong background in leading and managing people.
• A true team player with the ability to work collaboratively with key internal stakeholders.
• Must adhere to Skyhawk’s core values, policies, procedures and business ethics.

Skyhawk Therapeutics is committed to pay transparency and equitable compensation practices. The base salary range for the Executive Director, Patient Support Services is $200,000–$315,000 annually. This range reflects the minimum and maximum target for such a position. Skyhawk Therapeutics will assess the appropriate level for a qualified candidate based on job‑related skills, professional experience, and relevant education or training.

Skyhawk is committed to discovering, developing and commercializing small molecule therapeutics that modify RNA expression. We use our novel SkySTAR® platform (Skyhawk Small molecule Therapeutics for Alternative splicing of RNA) to develop drug candidates directed toward targets for some of the world’s most intractable diseases including neurological conditions, cancer, and traditionally “undruggable” targets.

As set forth in Skyhawk Therapeutics’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

We collect voluntary disability information in compliance with federal law. Public burden statement:
According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.